Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway

Domain:

healthcare
Creator:
RobJumHwaDan
Publisher:
ope
Host:
Abstract Background HIV infection dysregulates the B cell compartment, affecting memory B cell formation and the antibody response to infection and vaccination. Understanding the B cell response to SARS-CoV-2 in people living with HIV (PLWH) may explain the increased morbidity, reduced vaccine efficacy, reduced clearance, and intra-host evolution of SARS-CoV-2 observed in some HIV-1 coinfections. Methods We compared B cell responses to COVID-19 in PLWH and HIV negative (HIV-ve) patients in a cohort recruited in Durban, South Africa, during the first pandemic wave in July 2020 using detailed flow cytometry phenotyping of longitudinal samples with markers of B cell maturation, homing and regulatory features. Results This revealed a coordinated B cell response to COVID-19 that differed significantly between HIV-ve and PLWH. Memory B cells in PLWH displayed evidence of reduced germinal center (GC) activity, homing capacity and class-switching responses, with increased PD-L1 expression, and decreased Tfh frequency. This was mirrored by increased extrafollicular (EF) activity, with dynamic changes in activated double negative (DN2) and activated naïve B cells, which correlated with anti-RBD-titres in these individuals. An elevated SARS-CoV-2 specific EF response in PLWH was confirmed using viral spike and RBD bait proteins. Conclusions Despite similar disease severity, these trends were highest in participants with uncontrolled HIV, implicating HIV in driving these changes. EF B cell responses are rapid but give rise to lower affinity antibodies, less durable long-term memory, and reduced capacity to adapt to new variants. Further work is needed to determine the long-term effects of HIV on SARS-CoV-2 immunity, particularly as new variants emerge. Funding This work was supported by a grant from the Wellcome Trust to the Africa Health Research Institute (Wellcome Trust Strategic Core Award [grant number 201433/Z/16/Z]). Additional funding was received from the South African Department of Science and Innovation through the National Research Foundation (South African Research Chairs Initiative, [grant number 64809]), and the Victor Daitz Foundation.

Visit

doi.org

Similar

misita-falcon/SARS-CoV-2-Manuscript-2021: SARS-CoV-2-Manuscript-2021Genomic Surveillance of SARS-CoV-2 in Ghana: Leveraging an Integrated National Influenza and SARS-CoV-2 PlatformHIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection waveLoss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunityPerformance evaluation of the SARS-CoV-2 detection kit: MAScIR SARS-CoV-2 M kit 2.0.Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020

misita-falcon/SARS-CoV-2-Manuscript-2021: SARS-CoV-2-Manuscript-2021

Code and script for generating figures and tables for the Genetic diversity of SARS-CoV-2 infections

Genomic Surveillance of SARS-CoV-2 in Ghana: Leveraging an Integrated National Influenza and SARS-CoV-2 Platform

HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave

There are conflicting reports on the effects of HIV on COVID-19. Here, we analyzed disease severity

Loss of recognition of SARS-CoV-2 B.1.351 variant spike epitopes but overall preservation of T cell immunity

Abstract SARS-CoV-2 variants have emerged that escape neutralization and potential

Performance evaluation of the SARS-CoV-2 detection kit: MAScIR SARS-CoV-2 M kit 2.0.

The aim of our study is to check the performance of the new 100% Moroccan SARS-CoV-2 detection kit:

Detection of B.1.351 SARS-CoV-2 Variant Strain — Zambia, December 2020